Servier, an independent pharma governed by a foundation, has published its financial results for the 2024/25 financial year.

US biotech Fortitude Biomedicines has emerged from stealth with $13 million in seed funding to develop a hybrid biologics ...

Swedish women’s health specialist Gedea Biotech today announces a planned chief executive (CEO) transition. After close to ...

Advicenne’s shares rose 6% to 1.76 euros this morning, on the news it has obtained both marketing authorization (MA) and ...

The Centers for Medicare & Medicaid Services (CMS) is seeking public input on ways to strengthen domestic supply chains for ...

The US Department of Health and Human Services (HHS) has ended the permitted use of human fetal tissue from elective abortion ...

Chinese biotech Huahui Health has won conditional approval for Libevitug (libevitug) to treat adults with chronic hepatitis D ...

Hangzhou, China-based privately-held HealZen Therapeutics has announced a new strategic partnership with an unnamed US ...

Chinese cell therapy company NewCure Biotech has raised more than 200 million yuan ($28 million) in a series B round to ...

A biotechnology company headquartered in Cambridge, Massachusetts. The company operates as a research-led organization ...

The pace of medical innovation is faster than ever, but patients often face delays in accessing transformative therapies. The ...

On January 6, 2025, the US Food and Drug Administration (FDA) issued draft guidance titled “Considerations for the Use of ...